CME Group (NASDAQ:CME) Insider Sells $3,075,606.85 in Stock

CME Group Inc. (NASDAQ:CME) insider Julie Winkler sold 10,079 shares of the stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $305.15, for a total value of $3,075,606.85. Following the transaction, the insider directly owned 21,482 shares of the company’s stock, valued at approximately $6,555,232.30. The trade was a 31.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

CME Group Stock Up 1.4%

Shares of CME stock opened at $308.27 on Thursday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock has a market cap of $110.34 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 3.71 and a beta of 0.15. The business’s fifty day moving average is $282.08 and its 200-day moving average is $280.52. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.68 EPS. Equities analysts expect that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of CME. Brookmont Capital Management lifted its position in CME Group by 0.6% in the third quarter. Brookmont Capital Management now owns 5,661 shares of the financial services provider’s stock worth $1,483,000 after purchasing an additional 34 shares during the period. Manchester Capital Management LLC boosted its stake in CME Group by 2.9% during the third quarter. Manchester Capital Management LLC now owns 1,297 shares of the financial services provider’s stock worth $340,000 after buying an additional 37 shares in the last quarter. NBT Bank N A NY boosted its stake in CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after buying an additional 38 shares in the last quarter. Resonant Capital Advisors LLC increased its holdings in CME Group by 3.8% in the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock valued at $317,000 after buying an additional 39 shares during the period. Finally, Grove Bank & Trust increased its holdings in CME Group by 0.8% in the 3rd quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock valued at $1,320,000 after buying an additional 39 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Wall Street Zen upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Saturday, October 31st. Wells Fargo & Company raised their price objective on shares of CME Group from $315.00 to $333.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price objective on the stock in a research note on Thursday, October 22nd. CLSA set a $367.00 price objective on shares of CME Group in a research note on Thursday, October 22nd. Finally, TD Cowen boosted their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a report on Monday, October 5th. Ten investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $314.44.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: October weekend trading in crypto reportedly reached a record $1.3 billion on CME, while coverage also highlights record trading volumes. Sustained activity could lift transaction-related revenue. Weekend crypto trading article Record trading volumes article
• Positive Sentiment: CME Group’s market-data revenue reached a record $243 million last quarter, adding a recurring revenue source alongside trading fees. Market-data revenue article
• Neutral Sentiment: The CFTC’s approval of stock perpetual futures for U.S. registered exchanges could expand the futures market, but the report does not establish how much CME Group may benefit. CFTC stock perpetual futures article
• Negative Sentiment: Two insiders sold shares on Nov. 2: Julie Winkler sold 10,079 shares, reducing her position by about 32%, and director Howard Siegel sold 2,000 shares, cutting his holdings by about 9%. Such sales may weigh on sentiment, although both retained shares. Insider sales report

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.